BRA Stock Overview
Braster S.A. provides in-home breast cancer examination device worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Braster S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł0.58 |
52 Week High | zł0.94 |
52 Week Low | zł0.53 |
Beta | 0.73 |
1 Month Change | 0% |
3 Month Change | -4.92% |
1 Year Change | -26.21% |
3 Year Change | -10.77% |
5 Year Change | -84.90% |
Change since IPO | -96.10% |
Recent News & Updates
Recent updates
Does Braster (WSE:BRA) Have A Healthy Balance Sheet?
Mar 23Health Check: How Prudently Does Braster (WSE:BRA) Use Debt?
Oct 14Is Braster (WSE:BRA) Using Debt Sensibly?
Jun 21Braster (WSE:BRA) Has Debt But No Earnings; Should You Worry?
Mar 07Is Braster (WSE:BRA) Weighed On By Its Debt Load?
Nov 20Is Braster (WSE:BRA) A Risky Investment?
Jul 28Does Braster (WSE:BRA) Have A Healthy Balance Sheet?
Feb 04Shareholder Returns
BRA | PL Medical Equipment | PL Market | |
---|---|---|---|
7D | 0% | -1.2% | 3.5% |
1Y | -26.2% | -6.5% | 27.4% |
Return vs Industry: BRA underperformed the Polish Medical Equipment industry which returned 7.3% over the past year.
Return vs Market: BRA underperformed the Polish Market which returned 24.7% over the past year.
Price Volatility
BRA volatility | |
---|---|
BRA Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 4.7% |
Market Average Movement | 5.1% |
10% most volatile stocks in PL Market | 9.6% |
10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: BRA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BRA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 14 | Dariusz Karolak | www.braster.eu |
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination through Braster telemedical centers.
Braster S.A. Fundamentals Summary
BRA fundamental statistics | |
---|---|
Market cap | zł17.04m |
Earnings (TTM) | -zł3.62m |
Revenue (TTM) | zł2.14m |
8.0x
P/S Ratio-4.7x
P/E RatioIs BRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BRA income statement (TTM) | |
---|---|
Revenue | zł2.14m |
Cost of Revenue | zł595.00k |
Gross Profit | zł1.54m |
Other Expenses | zł5.17m |
Earnings | -zł3.62m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Sep 27, 2023
Earnings per share (EPS) | -0.12 |
Gross Margin | 72.18% |
Net Profit Margin | -169.33% |
Debt/Equity Ratio | 702.8% |
How did BRA perform over the long term?
See historical performance and comparison